[ad_1]
![RBFOX2 is differentially expressed and alternatively spliced in pancreatic cancer. RBFOX2 expression analysis using microarray data from GEO dataset GSE28735 27 showed a significant increase in RBFOX2 expression in tumors (n = 45) compared to normal pancreas (n = 45) (a FDR adj. P = 0.006, two-sided t-test). Gene expression analysis of CPTAC RNA-seq data34 generated from normal pancreas and resected pancreatic cancer specimens showed RBFOX2 gene expression is significantly higher in tumors of the basal subtype (n = 54) compared to normal pancreas (n = 19) (b adj. P < 0.0001, ordinary one-way ANOVA with Tukey’s multiple comparisons, DF = 138) and no difference between normal pancreas and the classical subtype (n = 70) (adj. P = 0.2135, two-sided t-test). RBFOX2 expression is significantly increased in basal (n = 48) compared to classical (n = 56) PDAC in RNA-seq data from E-MTAB-683035 (c Wilcoxon Rank-sum test, P = 0.00023). The canonical full length RBFOX2 transcript includes two N-terminal two exons encode an N-terminal nuclear localization signal, while downstream exon 10 (ENSG00000100320:015) encodes an internal NLS (d). RBFOX2 transcripts in the pancreas utilize an internal start codon present in exon 3 and lack the N-terminal exons. RBFOX2 transcripts show alternative splicing of exon 10 in mature transcripts. The RBFOX2 recognition sequence UCGAUG is present upstream of exon 10 (e). RBFOX2 binding at this site is predicted to facilitate skipping of exon 10 in mature transcripts. Analysis of percent spliced-in (PSI), a measure of exon inclusion, for alternatively spliced RBFOX2 exon 10 in RBFOX2transcripts shows a significant increase in the inclusion of exon 10 in normal pancreas (n = 20) compared to PDAC (n = 136), (f CPTAC, P < 0.0001, 2-tailed t-test, t = 4.700, df=159). RBFOX2 exon 10 PSI was significantly different between classical and basal PDAC tumors (g CPTAC34, P = 0.0365, 2-tailed t-test, t = 2.115, df=117). Samples ±2 SD from the population mean were removed prior to statistical analysis. Data are presented as mean values +/- SD. The box plots define the 25th and 75th percentiles (box), median (solid line) and the minima and maxima (whiskers). Statistical analysis was performed using PRISM and the P-values reported for the indicated statistical tests are shown. Source data are provided as a Source data file. Credit: Nature Communications (2023). DOI: 10.1038/s41467-023-44126-w Deregulation of alternative RNA splicing promotes pancreatic cancer progression and metastasis](https://scx1.b-cdn.net/csz/news/800a/2024/deregulation-of-altern.jpg)
RBFOX2 is differentially expressed and alternatively spliced in pancreatic most cancers. RBFOX2 expression evaluation utilizing microarray information from GEO dataset GSE28735 27 confirmed a major improve in RBFOX2 expression in tumors (n = 45) in comparison with regular pancreas (n = 45) (a FDR adj. P = 0.006, two-sided t-test). Gene expression evaluation of CPTAC RNA-seq information34 generated from regular pancreas and resected pancreatic most cancers specimens confirmed RBFOX2 gene expression is considerably increased in tumors of the basal subtype (n = 54) in comparison with regular pancreas (n = 19) (b adj. P < 0.0001, unusual one-way ANOVA with Tukey’s a number of comparisons, DF = 138) and no distinction between regular pancreas and the classical subtype (n = 70) (adj. P = 0.2135, two-sided t-test). RBFOX2 expression is considerably elevated in basal (n = 48) in comparison with classical (n = 56) PDAC in RNA-seq information from E-MTAB-683035 (c Wilcoxon Rank-sum check, P = 0.00023). The canonical full size RBFOX2 transcript consists of two N-terminal two exons encode an N-terminal nuclear localization sign, whereas downstream exon 10 (ENSG00000100320:015) encodes an inside NLS (d). RBFOX2 transcripts within the pancreas make the most of an inside begin codon current in exon 3 and lack the N-terminal exons. RBFOX2 transcripts present different splicing of exon 10 in mature transcripts. The RBFOX2 recognition sequence UCGAUG is current upstream of exon 10 (e). RBFOX2 binding at this web site is predicted to facilitate skipping of exon 10 in mature transcripts. Evaluation of % spliced-in (PSI), a measure of exon inclusion, for alternatively spliced RBFOX2 exon 10 in RBFOX2transcripts reveals a major improve within the inclusion of exon 10 in regular pancreas (n = 20) in comparison with PDAC (n = 136), (f CPTAC, P < 0.0001, 2-tailed t-test, t = 4.700, df=159). RBFOX2 exon 10 PSI was considerably completely different between classical and basal PDAC tumors (g CPTAC34, P = 0.0365, 2-tailed t-test, t = 2.115, df=117). Samples ±2 SD from the inhabitants imply have been eliminated previous to statistical evaluation. Information are introduced as imply values +/- SD. The field plots outline the twenty fifth and seventy fifth percentiles (field), median (stable line) and the minima and maxima (whiskers). Statistical evaluation was carried out utilizing PRISM and the P-values reported for the indicated statistical exams are proven. Supply information are offered as a Supply information file. Credit score: Nature Communications (2023). DOI: 10.1038/s41467-023-44126-w
Pancreatic most cancers presents a difficult prognosis, marked by a five-year general survival price of merely 12.5%. Prognosis often happens at a sophisticated stage, characterised by metastasis to distant websites. The intricate molecular mechanisms governing pancreatic most cancers metastasis stay a topic of ongoing analysis and exploration.
In a current article published in Nature CommunicationsMoffitt Most cancers Heart researchers, in collaboration with The Tisch Most cancers Institute; St. Jude Youngsters’s Analysis Hospital; the Company for Science, Know-how and Analysis in Singapore; and the College of Otago in New Zealand, reveal that deregulation of a protein referred to as RBFOX2, concerned in RNA splicing, contributes to the development and metastasis of pancreatic cancer.
RNA is a nucleic acid that promotes the synthesis of proteins. Whereas the nucleotide sequence of RNA is encoded by the DNA of the genome, RNA molecules bear a number of modifications earlier than finally coming into the ribosome to make protein. An essential course of that modifies RNA sequences is alternative splicingwhereby particular sequences inside the RNA molecule could also be rearranged, included or excluded.
This course of ends in completely different variations of RNA molecules generated from a single DNA sequence that may produce protein variants with doubtlessly completely different actions. Various RNA splicing is essential for a lot of cellular processes; nevertheless, the involvement of different RNA splicing in most cancers growth isn’t totally understood.
The analysis workforce needed to evaluate whether or not different RNA splicing is concerned within the growth and development of pancreatic most cancers. By molecular-based laboratory experiments and mouse fashions, they found that RNA-binding proteins concerned in splicing regulation have been concerned in pancreatic most cancers development. One of many key proteins they recognized is RBFOX2.
Outcomes confirmed RBFOX2 protein ranges have been decrease in pancreatic most cancers cells that had metastasized to different websites. These observations recommend that RBFOX2 could also be a tumor suppressor protein that usually capabilities to inhibit most cancers metastasis. The researchers confirmed this speculation by demonstrating that lack of RBFOX2 in pancreatic cell strains and mouse fashions elevated cell migrationinvasion, tumor growth and metastasis.
The researchers carried out extra experiments to find out the downstream pathways impacted by RBFOX2 that result in pancreatic most cancers development.
They discovered that RBFOX2 regulates the splicing of RNA molecules that code for proteins concerned in cytoskeletal reworking, with one of many essential molecules being RNA that codes for the protein ABI1. In cells with out RBFOX2, the placement of ABI1 is redistributed to the cell periphery, the place it impacts the cell cytoskeleton and promotes cell migration.
These mixed observations reveal the significance of different RNA splicing to pancreatic most cancers development and recommend the necessity for added research to grasp the mechanisms regulating RBFOX2 splicing exercise totally.
“Whereas analyses to this point have identified few splicing regulators with prognostic implications in pancreatic most cancers, the incidence of exon splicing occasions conserved throughout pancreatic tumors and different cancers suggests the processes regulated by alternatively spliced transcripts are integral to cancer development,” stated Karen Mann, Ph.D., assistant member of the Division of Molecular Oncology at Moffitt.
Extra info:
Michelle Maurin et al, RBFOX2 deregulation promotes pancreatic most cancers development and metastasis by way of different splicing, Nature Communications (2023). DOI: 10.1038/s41467-023-44126-w
Quotation:
Examine finds lack of RBFOX2 protein promotes pancreatic most cancers metastasis by way of results on cytoskeletal reworking (2024, January 11)
retrieved 14 January 2024
from https://medicalxpress.com/information/2024-01-loss-rbfox2-protein-pancreatic-cancer.html
This doc is topic to copyright. Aside from any honest dealing for the aim of personal examine or analysis, no
half could also be reproduced with out the written permission. The content material is offered for info functions solely.
[ad_2]
Source link
Discussion about this post